ATE497762T1 - Verwendung von diindolylmethan-verwandten indolen zur behandlung und prävention von erkrankungen im zusammenhang mit dem respiratory syncytial virus - Google Patents

Verwendung von diindolylmethan-verwandten indolen zur behandlung und prävention von erkrankungen im zusammenhang mit dem respiratory syncytial virus

Info

Publication number
ATE497762T1
ATE497762T1 AT05857257T AT05857257T ATE497762T1 AT E497762 T1 ATE497762 T1 AT E497762T1 AT 05857257 T AT05857257 T AT 05857257T AT 05857257 T AT05857257 T AT 05857257T AT E497762 T1 ATE497762 T1 AT E497762T1
Authority
AT
Austria
Prior art keywords
diindolylmethane
prevention
treatment
rsv
syncytial virus
Prior art date
Application number
AT05857257T
Other languages
English (en)
Inventor
Michael Zeligs
Original Assignee
Bioresponse Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioresponse Llc filed Critical Bioresponse Llc
Application granted granted Critical
Publication of ATE497762T1 publication Critical patent/ATE497762T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
AT05857257T 2004-12-30 2005-12-30 Verwendung von diindolylmethan-verwandten indolen zur behandlung und prävention von erkrankungen im zusammenhang mit dem respiratory syncytial virus ATE497762T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64030104P 2004-12-30 2004-12-30
PCT/US2005/047537 WO2006083458A2 (en) 2004-12-30 2005-12-30 Use of diindolylmethane-related indoles for the treatment and prevention of respiratory syncytial virus associates conditions

Publications (1)

Publication Number Publication Date
ATE497762T1 true ATE497762T1 (de) 2011-02-15

Family

ID=36777712

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05857257T ATE497762T1 (de) 2004-12-30 2005-12-30 Verwendung von diindolylmethan-verwandten indolen zur behandlung und prävention von erkrankungen im zusammenhang mit dem respiratory syncytial virus

Country Status (6)

Country Link
US (2) US7989486B2 (de)
EP (1) EP1838303B1 (de)
AT (1) ATE497762T1 (de)
CA (1) CA2593084C (de)
DE (1) DE602005026328D1 (de)
WO (1) WO2006083458A2 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
BRPI0511834A (pt) 2004-07-14 2008-01-08 Ptc Therapeutics Inc métodos por tratar hepatite c
DE602005026328D1 (de) * 2004-12-30 2011-03-24 Bioresponse Llc Verwendung von diindolylmethan-verwandten indolen zur behandlung und prävention von erkrankungen im zusammenhang mit dem respiratory syncytial virus
US20070059310A1 (en) * 2005-05-03 2007-03-15 Karel Steven J Therapeutic combination compositions and methods of using same
WO2007016935A1 (en) * 2005-07-29 2007-02-15 Histogenex Nv Methods, reagents and instrumentation for preparing impregnated tissue samples suitable for histopathological and molecular studies
BRPI0717753B1 (pt) 2006-10-27 2022-04-12 Bioresponse, Llc Uso de uma composição compreendendo 50-250 mg de um ou mais indóis relacionados com dim e um ou mais agentes anti-protozoários, e, composição
WO2009103755A1 (en) * 2008-02-19 2009-08-27 Dsm Ip Assets B.V. Novel use of 3,3'-diindolylmethane
WO2010026029A1 (en) * 2008-09-03 2010-03-11 Boehringer Ingelheim International Gmbh Use of quinazoline derivatives for the treatment of viral diseases
JP5550151B2 (ja) 2008-09-17 2014-07-16 エスアールアイ インターナショナル インドール−３−カルビノール類似体およびその感染に対する薬剤としての使用
AU2009344851A1 (en) * 2008-12-19 2011-06-23 The Regents Of The University Of California Use of epidermal growth factor inhibitors in the treatment of viral infection
CN101428016B (zh) * 2008-12-23 2011-06-15 南京大学 二吲哚甲烷及其衍生物在制备治疗类风湿关节炎的药物中的应用
WO2010118339A2 (en) * 2009-04-09 2010-10-14 University Of Kansas Formulations of indole-3-carbinol derived antitumor agents with increased oral bioavailability
GB201004761D0 (en) * 2010-03-22 2010-05-05 Medical Res Council Method
CN102133210A (zh) * 2010-04-28 2011-07-27 重庆医科大学附属儿童医院 白藜芦醇在制备预防和治疗呼吸道合胞病毒感染的药物中的应用
KR20130091761A (ko) * 2010-08-18 2013-08-19 클레어파르마 인더스트리즈 리미티드. 기능성 식품 조성물 및 그 제조방법
GB201105050D0 (en) 2011-03-25 2011-05-11 Iiaa Ltd Pharmaceutical agent
CA2827214C (en) 2011-04-01 2017-07-18 Sri International Lipoxygenase inhibitors
US20150297593A1 (en) * 2012-09-14 2015-10-22 Children's Medical Center Corporation Inhibition of viral infection-triggered asthma with c-kit inhibitor
CN105272900B (zh) * 2015-01-21 2018-06-19 南通大学 双吲哚类衍生物及其制备方法与应用
WO2016164770A1 (en) 2015-04-10 2016-10-13 Bioresponse, L.L.C. Self-emulsifying formulations of dim-related indoles
CN105030766A (zh) * 2015-06-24 2015-11-11 安徽四正医药科技有限公司 吲哚-3-甲醇、二吲哚甲烷及其衍生物用于治疗过敏性咽炎药物的应用
WO2017001979A1 (en) * 2015-06-27 2017-01-05 Reform Bio Inc. Diindolyl methane compositions, formulations and use thereof
CN110074978A (zh) * 2019-03-13 2019-08-02 安庆瑄宇医药科技有限公司 一种缬更昔洛韦组合片剂及其制备方法
RU2740377C1 (ru) * 2020-03-18 2021-01-13 Всеволод Иванович Киселёв Способ лечения эндометриоза и сопутствующего спаечного процесса лекарственным средством на основе 3,3'-дииндолилметана в комплексе с B-циклодекстрином
CA3179635A1 (en) 2020-05-29 2021-12-02 Boulder Bioscience Llc Methods for improved endovascular thrombectomy using 3,3'-diindolylmethane
CN116585321B (zh) * 2023-02-21 2024-04-26 华中科技大学同济医学院附属协和医院 更昔洛韦在制备治疗过敏性鼻炎药物中的应用

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5718921A (en) 1987-03-13 1998-02-17 Massachusetts Institute Of Technology Microspheres comprising polymer and drug dispersed there within
FR2676927B1 (fr) 1991-05-29 1995-06-23 Ibf Microspheres utilisables pour les occlusions vasculaires therapeutiques et solutions injectables les contenant.
AU661533B2 (en) 1992-01-20 1995-07-27 Astrazeneca Ab Quinazoline derivatives
DK0656786T3 (da) 1992-05-19 2004-11-08 Novogen Res Pty Ltd Anvendelse af isoflavonphytoöstrogenekstrakter af soja eller klöver
CA2216796C (en) 1995-03-30 2003-09-02 Pfizer Inc. Quinazoline derivatives
GB9508538D0 (en) 1995-04-27 1995-06-14 Zeneca Ltd Quinazoline derivatives
KR100437582B1 (ko) 1995-07-06 2004-12-17 노파르티스 아게 피롤로피리미딘및그들의제조방법
US6127393A (en) 1995-12-29 2000-10-03 Novactyl, Inc. Antiproliferative, antiinfective, antiinflammatory, autologous immunization agent and method
US5767135A (en) 1995-12-29 1998-06-16 Fernandez-Pol; Jose Alberto Antiviral agent
GB9603095D0 (en) 1996-02-14 1996-04-10 Zeneca Ltd Quinazoline derivatives
CA2249446C (en) 1996-04-12 2008-06-17 Warner-Lambert Company Irreversible inhibitors of tyrosine kinases
US5948808A (en) 1997-03-07 1999-09-07 The Texas A&M University System Indole-3-carbinol, diindolylmethane and substituted analogs as antiestrogens
CA2284039A1 (en) 1997-03-18 1998-09-24 Ortho-Mcneil Pharmaceutical, Inc. Methods and kits for treating and diagnosing leiomyomas
US6083932A (en) 1997-04-18 2000-07-04 Cv Technologies Inc. Pharmaceutical compositions derived from ginseng and methods of treatment using same
US6001868A (en) 1997-05-30 1999-12-14 The Regents Of The University Of California Indole-3-carbinol (I3C) derivatives and methods
US6150395A (en) 1997-05-30 2000-11-21 The Regents Of The University Of California Indole-3-carbinol (I3C) derivatives and methods
US5895787A (en) 1997-10-08 1999-04-20 Designed Nutritional Products, Inc. Treatment of fibromyalgia and related disorders
US6086915A (en) * 1998-04-01 2000-07-11 Bioresponse L.L.C. Compositions and methods of adjusting steroid hormone metabolism through phytochemicals
ATE295839T1 (de) 1998-04-29 2005-06-15 Osi Pharm Inc N-(3-ethinylphenylamino)-6,7-bis(2-methoxyethox )-4-chinazolinamin-mesylat-anhydrat und -monohydrat
WO2000002857A1 (en) 1998-07-08 2000-01-20 Harbor Branch Oceanographic Institution, Inc. Bis-indole derivatives and their use as antiinflammatory agents
PT1131304E (pt) 1998-11-19 2003-04-30 Warner Lambert Co N-¬4-(3-cloro-4-fluoro-fenilamino)-7-(3-morfolin-4-il-propoxi)-quinazolin-6-il|-acrilamida um inibidor irreversivel de tirosino quinases
US6613792B1 (en) 1999-08-02 2003-09-02 Designed Nutritional Products, Inc. Treatment of premenstrual syndrome and menopause
US6534085B1 (en) 1999-09-23 2003-03-18 Bioresponse L.L.C. Phytochemicals for promoting weight loss
US7384971B2 (en) 1999-09-23 2008-06-10 Bioresponse L.L.C. Phytochemicals for the treatment of cervical dysplasia
US6689387B1 (en) 1999-09-23 2004-02-10 Bioresponse Llc Phytochemicals for treatment of mastalgia and endometriosis
AU775459B2 (en) 1999-10-04 2004-08-05 Lawrence R. Bernstein Gallium complexes of 3-hydroxy-4-pyrones to treat infection by intracellular prokaryotes, DNA viruses and retroviruses
US6676971B2 (en) 2000-03-13 2004-01-13 Biocure, Inc. Embolic compositions
US6399645B1 (en) 2000-03-20 2002-06-04 Maria Bell Chemoprevention and treatment of cervical or vaginal neoplasia
CN1430505A (zh) 2000-03-24 2003-07-16 生物领域医疗公司 用于主动栓塞术的微球体
US6477229B1 (en) 2000-05-12 2002-11-05 Siemens Medical Solutions Usa, Inc. Radiation therapy planning
US6416793B1 (en) 2000-07-11 2002-07-09 Bioresponse, L.L.C. Formulations and use of controlled-release indole alkaloids
US7709520B2 (en) 2000-10-06 2010-05-04 The Texas A&M University System Diindolylmethane and C-substituted diindolylmethane compositions and methods for the treatment of multiple cancers
US6468557B1 (en) 2001-01-05 2002-10-22 Alphamed Pharmaceutical Corp. Method for treating infectious viral diseases
US20020147155A1 (en) 2001-04-06 2002-10-10 Foster Warren G. Prevention and treatment of endometriosis with aryl hydrocarbon receptor binding ligands
US7030150B2 (en) * 2001-05-11 2006-04-18 Trimeris, Inc. Benzimidazole compounds and antiviral uses thereof
EP1269994A3 (de) 2001-06-22 2003-02-12 Pfizer Products Inc. Pharmazeutische Zusammensetzungen die ein Arzneimittel und die Konzentration verbesserende Polymere enthalten
US7348352B2 (en) 2001-10-23 2008-03-25 Bioresponse L.L.C. Diindolylmethane for the treatment of HPV infection
US6544564B1 (en) * 2001-11-27 2003-04-08 Michael Donald Farley Cytotoxic pharmaceutical composition
TW200408407A (en) * 2001-11-30 2004-06-01 Dana Farber Cancer Inst Inc Methods and compositions for modulating the immune system and uses thereof
US20030220377A1 (en) 2002-05-08 2003-11-27 Richard Chesworth Indole compounds and their use as estrogen agonists/antagonists
US6800655B2 (en) 2002-08-20 2004-10-05 Sri International Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents
ES2391770T3 (es) * 2003-01-21 2012-11-29 Novartis Vaccines And Diagnostics, Inc. Uso de compuestos de triptantrina para la potenciación inmune
EP1601367A2 (de) 2003-02-06 2005-12-07 Bioresponse L.L.C. Kombinierte benutzung von kreuzblütler-indolen und chelatbildenden mitteln zur behandlung von durch den papillomavirus bedingten zuständen
US20040235931A1 (en) * 2003-04-17 2004-11-25 John Docherty Inhibition of herpes virus replication
US20050123560A1 (en) * 2003-12-04 2005-06-09 Sinnott Robert A. High purity and water dispersible extract and formulations of larrea tridentata leaf resin, and methods of making and using the same
US8080577B2 (en) 2004-05-06 2011-12-20 Bioresponse, L.L.C. Diindolylmethane formulations for the treatment of leiomyomas
WO2006047716A2 (en) * 2004-10-26 2006-05-04 Bioresponse Llc Use of diindolylmethane-related indoles and growth factor receptor inhibitors for the treatment of human cytomegalovirus associated disease
US20060100264A1 (en) * 2004-11-06 2006-05-11 Bjeldanes Leonard F 3,3'-Diindolylmethane immune activating compositions
DE602005026328D1 (de) 2004-12-30 2011-03-24 Bioresponse Llc Verwendung von diindolylmethan-verwandten indolen zur behandlung und prävention von erkrankungen im zusammenhang mit dem respiratory syncytial virus
US20060229355A1 (en) 2005-04-08 2006-10-12 The Regents Of The University Of California 3.3'-Diindolylmethane compositions inhibit angiogenesis

Also Published As

Publication number Publication date
EP1838303B1 (de) 2011-02-09
CA2593084C (en) 2014-03-18
EP1838303A4 (de) 2008-06-18
CA2593084A1 (en) 2006-08-10
US8552052B2 (en) 2013-10-08
WO2006083458A2 (en) 2006-08-10
EP1838303A2 (de) 2007-10-03
US20080103114A1 (en) 2008-05-01
WO2006083458A3 (en) 2007-10-04
US20110250267A1 (en) 2011-10-13
US7989486B2 (en) 2011-08-02
DE602005026328D1 (de) 2011-03-24

Similar Documents

Publication Publication Date Title
ATE497762T1 (de) Verwendung von diindolylmethan-verwandten indolen zur behandlung und prävention von erkrankungen im zusammenhang mit dem respiratory syncytial virus
ATE425965T1 (de) 1,2,3,4-tetrasubstituiertes indol zur behandlung von atemwegserkrankungen
ATE430154T1 (de) Amino-substituierte cyclohexan derivate zur behandlung bakterieller infektionen
NO20083501L (no) Azaindoler som er anvendelige som inhibitorer for Janus-kinaser
ATE438404T1 (de) Verwendung von k-252a und kinasehemmern zur vorbeugung und behandlung von hmgb1-assoziierten pathologien
DE602005009748D1 (de) 3-phenyl-pyrazol-derivate als modulatoren des zur behandlung damit zusammenhängender störungen nützlichen 5-ht-2a-serotonin-rezeptors
ATE448219T1 (de) Neue hydantoinderivate zur behandlung von obstruktiven atemwegserkrankungen
ATE449602T1 (de) Arzneimittel mit dobesilat-calcium zur behandlung und prophylaxe von sehnenerkrankungen
WO2006047716A3 (en) Use of diindolylmethane-related indoles and growth factor receptor inhibitors for the treatment of human cytomegalovirus associated disease
MX2010002319A (es) Derivados indolicos 2,3 sustituidos para el tratamiento de infecciones virales.
TW200733953A (en) Materials and methods for treating viral infections
EP3311818A3 (de) Hemmer der bruton-tyrosinkinase zur behandlung solider tumore
EA201100505A1 (ru) Органические соединения для применения для лечения бактериальных инфекций
ATE512948T1 (de) Biphenyl-sulfonyl- und phenyl-heteroaryl-sulfonyl-modulatoren des histamin-h3-rezeptors zur behandlung von damit verbundenen erkrankungen
DE602005026276D1 (de) Myricitrin verbindungen zur behandlung von schlafstörungen
ATE462438T1 (de) Verwendung von carrageenan zur behandlung von rhinovirus-infektionen
ATE555108T1 (de) Polyamide zur behandlung des menschlichen papilloma-virus
DE60312736D1 (de) 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems
WO2008135983A3 (en) Recombinant human fibrinogen for treatment of bleeding in trauma and platelet disorders
DE602007006328D1 (de) 1h-indol-6-ylpiperazin-1-ylmethanonderivate zur verwendung als h3-rezeptormodulatoren
DE602005007765D1 (de) Neue indol- oder benzimidazol-derivate
ATE432275T1 (de) Pyrrol- bzw. imidazolamide zur behandlung von obesitas
ATE410235T1 (de) Behandlung von ballastwasser
DE102004016179A1 (de) Verbindungen zur Behandlung von proliferativen Prozessen
WO2006101910A3 (en) Peptide compounds and methods of using peptide compounds to treat conditions affecting the cardiac, pulmonary, and nervous systems

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties